FdaApplication

ANDA 211382

Back to search

Identifiers

Properties

PropertyValue
applicant_nameFRESENIUS KABI USA LLC
application_typeANDA
approval_date2020-11-03

Products (1)

ProductActive ingredientStrengthDosage form
NOREPINEPHRINE BITARTRATENOREPINEPHRINE BITARTRATEEQ 1MG BASE/MLINJECTABLE;INJECTION

1 product